The comparison between JAT and RHT is somewhat bewildering to me as each stock is in a different space, is a different proposition and has a different (prospective) customer base.
But seeing as it's been brought up here I will say that a radiographer friend of mine has assured me RHT will not gain traction in Australia, mainly because it doesn't offer anything that can't already be provided by a simple blood test.
I certainly wish I'd jumped on for the ride from 3.5 cents to >10 cents but that's a separate matter to the longer term prospects of RHT.
The comparison between JAT and RHT is somewhat bewildering to me...
Add JAT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.070(16.9%) |
Mkt cap ! $40.38M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 49.5¢ | 41.5¢ | $92.01K | 197K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 33334 | 1 |
View Market Depth
| Last trade - 15.32pm 14/11/2024 (20 minute delay) ? |
| JAT (ASX) Chart |